Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target

Journal article

Ragotte RJ. et al, (2020), Trends in Parasitology, 36, 545 - 559

Design of a basigin‐mimicking inhibitor targeting the malaria invasion protein RH5

Journal article

Warszawski S. et al, (2020), Proteins: Structure, Function, and Bioinformatics, 88, 187 - 195

Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody

Journal article

Rawlinson TA. et al, (2019), Nature Microbiology, 4, 1497 - 1507

Adeno-associated viral vectored delivery of a monoclonal antibody gene against blood-stage malaria

Conference paper

Bardelli M. et al, (2019), HUMAN GENE THERAPY, 30, A11 - A11

New strategy of cancer vaccination by a hybrid bacteriophage vector and a malaria vaccine

Conference paper

Waramit S. et al, (2019), HUMAN GENE THERAPY, 30, A13 - A13

Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites

Journal article

Knuepfer E. et al, (2019), PLOS Pathogens, 15, e1007809 - e1007809

Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies

Journal article

Alanine DGW. et al, (2019), Cell, 178, 216 - 228.e21

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.

Journal article

Rijal P. et al, (2019), Cell Rep, 27, 172 - 186.e7

SnoopLigase peptide-peptide conjugation enables modular vaccine assembly

Journal article

HOWARTH MARK. et al, (2019), Scientific Reports

Load More